Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Gufic BioSciences Legal & Regulatory

Gufic Biosciences disclosed an ITAT Mumbai order for AY 2023-24 that set aside the CIT(A) findings and restored the matter to the Assessing Officer. No demand arises from the order, and the tax liability will be determined after fresh assessment.

Source

BSE filing, NSE: GUFICBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Gufic BioSciences Ltd: key numbers

Share price
₹427.80
Market cap
₹4,290 Cr
Revenue (annual)
₹944.0 Cr
Net profit (annual)
₹64.21 Cr
P/E (TTM)
58.4×Sector 41.3×
Promoter holding
72.50%+0.00% QoQ
FII holding
0.44%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gufic BioSciences Ltd

All →

Other legal & regulatory announcements

All →